Magna

News Magna

• Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery

  Fate Therapeutics, Inc. announced the appointment of Tom Novak, Ph.D., as vice president of research and drug discovery. Dr. Novak brings to Fate more than 15 years of experience working with large pharmaceutical companies, including Roche and Wyeth, to apply transformative technologies to advance e more

• Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit

  Pfizer announced that it has named Mace L. Rothenberg, M.D. as Senior Vice President, Clinical Development and Medical Affairs for its Oncology Business Unit. Dr. Rothenberg comes to Pfizer from Vanderbilt where he was Professor of Medicine at the Vanderbilt University Medical Center and Ingram Prof more

White papers Magna

• LightCycler® 480 System: High-throughput Gene Expression and Genotyping Analysis - A Performance Study
  

  The LightCycler® 480 System is a novel platform for rapid gene expression and melting curve-based genotyping for medium- and high-throughput. In order to assess the performance and ease-of-use of the complete LightCycler® 480 System (instrument, software, and reagents) in an academic laboratory setting we scheduled a high-throughput project including gene expression (39 targets in 88 samples = 3,400 expression values) as well as genotyping applications (3,808 genotypes; 14 SNPs in 288 samples). The project, involving five technicians and two graduate students, was accomplished within 15 working days. more

• MagNA Pure 96 Cellular RNA Kits: RNA Isolation on the Fast Lane
  

  Advancements in high-throughput gene expression analysis have set a new demand for automated isolation of cellular RNA from high sample numbers in parallel. The availability of the innovative MagNA Pure 96 System together with dedicated kits, protocols, and consumables sets a new standard in truly walkaway high-throughput automated nucleic acid sample preparation more

• The New MagNA Pure LC 2.0 System: New Design and Improved Performance Combined with a Proven Nucleic Acid Isolation Technology
  

  The fast, flexible, and reliable isolation of pure nucleic acids from various sample materials is crucial for sensitive molecular analysis by PCR, RT-PCR, sequencing, arrays etc. In addition, automation of nucleic acid isolation is becoming increasingly important. The MagNA Pure LC System from Roche Applied Science has been on the market since 1999. This fully automated ("walk-away") system is based on the well-established magnetic bead technology and offers a great variety of applications, e.g., isolation of DNA, RNA, and viral nucleic acid from various research sample materials such as blood, cells, plasma/serum, or tissue. more

Publications Magna

• Expanded Prader–Willi Syndrome Due to Chromosome 15q11.2–14 Deletion: Report and a Review of Literature

  Abstract We report on a male infant with de novo unbalanced t(5;15) translocation resulting in a 17.23 Mb deletion within 15q11.2–q14 and a 25.12 kb deletion in 5pter. The 15q11.2–q14 deletion encompassed the 15q11.2–q13 Prader–Willi syndrome (PWS) critical region and the recently described 15q more

• Integrated Consensus Map of Cultivated Peanut and Wild Relatives Reveals Structures of the A and B Genomes of Arachis and Divergence of the Legume Genomes

  The complex, tetraploid genome structure of peanut (Arachis hypogaea) has obstructed advances in genetics and genomics in the species. The aim of this study is to understand the genome structure of Arachis by developing a high-density integrated consensus map. Three recombinant inbred line populati more

• Fast and Specific Dermatophyte Detection by Automated DNA‐Extraction and Real‐Time PCR

  Abstract The aim of this study was to develop and validate a rapid and sensitive real‐time PCR method for detection of all known species of dermatophytes, including identification of Trichophyton rubrum and Trichophyton interdigitale. Fungal DNA was extracted directly from clinical samples by us more

Market studies Magna

• Goodman Co., Ltd. (7535) - Financial and Strategic SWOT Analysis Review

  Goodman Co., Ltd. (Goodman) is a medical device company engaged in the development, manufacture and selling of cardiology products. The company’s product line includes intravascular treatment catheters, intravascular diagnostic catheters, medical diagnostic equipment and artificial organs. Goodman o more

• Targanta Therapeutics Corporation - Strategic SWOT Analysis Review

  Targanta Therapeutics Corporation (TTC) is an privately held biopharmaceutical company, engaged in the development and commercialization of antibacterial drugs for the treatment of skin. TTC is an operational part of The Medicines Company, critical care hospital products provider. The company's prod more

• Magna-Lab Inc. (MAGAA) - Financial and Strategic SWOT Analysis Review

  Magna-Lab is a medical device company which is focused on the development and commercialization of disposable medical devices. These devices are designed to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company is headquartered in New York, more

Websites Magna